Molecular Oncology (United States)
In research, Molecular Oncology (United States) stands highest in Health Sciences (#634 of 9,902 worldwide), Medicine (#640 of 8,541 worldwide) and Life Sciences (#690 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Oncology, Molecular Biology and Biochemistry, Genetics and Molecular Biology (Oncology is 12.5× its share of world research).
- World rank, 2022-now
- #2,501 of 22,385 · #1,304 all time
- Rank in United States
- #435 of 3,332
- Research works
- 2.5k ▼ 16% vs 2018-21
- Citations
- 293k 118.9 per fractional work
- Top-10% rate
- 18.7% all institutions 10.0%
- vs its own fields
- 1.22× 1.00× is exactly expected
- Open access
- 57% world 40%
- International
- 43% world 18%
What is Molecular Oncology (United States) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #634 of 9,902 | 23.8% | 102 | #496 | |
| MedicineField | #640 of 8,541 | 23.7% | 99 | #505 | |
| Life SciencesDomain | #690 of 6,403 | 16.2% | 88 | #542 | |
| Biochemistry, Genetics and Molecular BiologyField | #428 of 2,964 | 16.0% | 73 | #387 |
Each strip is that field's whole ranked pool, with the notch where Molecular Oncology (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#496 #634
- Medicine#505 #640
- Life Sciences#542 #690
- Biochemistry, Genetics and Molecular Biology#387 #428
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Molecular Oncology (United States) work in?
In 2022-now, 51% of research at Molecular Oncology (United States) is in Health Sciences, 43% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (36%), Immunology and Microbiology (6%). It does 3.1× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 24 fields, with their numbers
- Health Sciences11650.8%
- Medicine11349.6%
- Dentistry10.5%
- Health Professions10.4%
- Nursing10.3%
- Veterinary00.0%
- Life Sciences9943.3%
- Physical Sciences125.1%
- Engineering52.0%
- Chemistry20.9%
- Materials Science20.9%
- Computer Science20.7%
- Environmental Science10.3%
- Physics and Astronomy00.2%
- Mathematics00.1%
- Earth and Planetary Sciences00.0%
- Chemical Engineering00.0%
- Social Sciences20.9%
- Psychology10.3%
- Arts and Humanities10.2%
- Social Sciences00.2%
- Economics, Econometrics and Finance00.2%
- Decision Sciences00.0%
What does Molecular Oncology (United States) specialise in?
Where its research is concentrated relative to its size: Oncology takes 12.5× the share of its output that it takes of world research.
- OncologySubfield · 32.2 works13×
- Molecular BiologySubfield · 48.0 works7.0×
- Biochemistry, Genetics and Molecular BiologyField · 81.7 works6.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.7×. Every wedge is a field page.
All 23 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology6.71×82 works
- Immunology and Microbiology5.55×13 works
- Medicine2.58×113 works
- Pharmacology, Toxicology and Pharmaceutics1.29×1 works
- Dentistry1.03×1 works
- Neuroscience0.65×2 works
- Nursing0.60×1 works
- Chemistry0.56×2 works
- Veterinary0.36×0 works
- Materials Science0.25×2 works
- Health Professions0.14×1 works
- Engineering0.13×5 works
- Mathematics0.12×0 works
- Computer Science0.09×2 works
- Physics and Astronomy0.09×0 works
- Psychology0.09×1 works
- Agricultural and Biological Sciences0.08×1 works
- Chemical Engineering0.08×0 works
- Arts and Humanities0.08×0 works
- Economics, Econometrics and Finance0.08×0 works
- Environmental Science0.05×1 works
- Earth and Planetary Sciences0.02×0 works
- Social Sciences0.02×0 works
- Biochemistry, Genetics and Molecular Biology 6.7×
- Immunology and Microbiology 5.5×
- Medicine 2.6×
- Pharmacology, Toxicology and Pharmaceutics 1.3×
- Dentistry 1.0×
- Neuroscience 0.7×
- Nursing 0.6×
- Chemistry 0.6×
- Veterinary 0.4×
- Materials Science 0.2×
- Health Professions 0.1×
- Engineering 0.1×
- Mathematics 0.1×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Psychology 0.1×
- Agricultural and Biological Sciences 0.1×
- Chemical Engineering 0.1×
- Arts and Humanities 0.1×
- Economics, Econometrics and Finance 0.1×
- Environmental Science 0.1×
- Earth and Planetary Sciences 0.0×
- Social Sciences 0.0×
Who are the top researchers at Molecular Oncology (United States)?
Ranked on the quality score, Frédéric J. de Sauvage, Hartmut Koeppen and Scot A. Marsters lead among researchers whose main affiliation is Molecular Oncology (United States).
- 1
Frédéric J. de Sauvage
United States · #1,016 worldwide 50k citations · 307 works
- 2
Hartmut Koeppen
United States · #12,562 worldwide 34k citations · 415 works
- 3
Scot A. Marsters
United States · #15,645 worldwide 17k citations · 137 works
- 4
Avi Ashkenazi
United States · #21,366 worldwide 42k citations · 372 works
- 5
Mark X. Sliwkowski
United States · #23,074 worldwide 33k citations · 302 works
- 6
Wyne P. Lee
United States · #23,765 worldwide 25k citations · 139 works
- 7
Dorothy M. French
United States · #26,225 worldwide 13k citations · 159 works
- 8
Paul G. Polakis
United States · #27,382 worldwide 29k citations · 244 works
- 9
Noelyn M. Kljavin
United States · #27,398 worldwide 7.3k citations · 95 works
- 10
Mark A. Merchant
United States · #30,291 worldwide 11k citations · 378 works
Which keywords describe research at Molecular Oncology (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Immunotherapy, Tumor Microenvironment, Chemotherapy, Targeted Therapy, Cancer Therapy, Prognostic Factors and Gene Expression.
- Cell Proliferation
- Breast Cancer
- Angiogenesis
- Genomic Profiling
- Survival Analysis
- PD-1 and PD-L1
- Immunity
- Transcriptional Regulation
- Molecular Characterization
- Cell Death
- Genetic Mutations
- Regulation
- Cancer Genomics
- Biomarkers
- Cell-Free DNA
- Gene Expression
- Prognostic Factors
- Cancer Therapy
- Chemotherapy
- Immunotherapy
- Cancer
- Tumor Microenvironment
- Targeted Therapy
- Inflammation
- Oxidative Stress
- Genomic Instability
- Clinical Trials
- Somatic Mutations
- Mutational Signatures
- Metastasis
- Apoptosis
- Clinical Practice Guidelines
- Radiotherapy
- Immune Checkpoint Blockade
- Neoadjuvant Therapy
- Stem Cells
- Cancer Immunotherapy
- Lymphoma
- Innate Immunity
- Cancer Progression
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer29▲ 9.4×41 topics
- Immunotherapy21▲ 12×15 topics
- Tumor Microenvironment18▲ 18×8 topics
- Chemotherapy16▲ 10×19 topics
- Targeted Therapy15▲ 30×5 topics
- Cancer Therapy14▲ 11×17 topics
- Inflammation13▲ 2.7×46 topics
- Prognostic Factors12▲ 12×12 topics
- Oxidative Stress11▲ 3.0×24 topics
- Gene Expression10▲ 7.2×12 topics
- Genomic Instability10▲ 38×2 topics
- Cell-Free DNA9▲ 40×2 topics
- Clinical Trials9▲ 5.9×9 topics
- Biomarkers9▲ 5.6×12 topics
- Somatic Mutations9▲ 47×2 topics
- Cancer Genomics9▲ 54×1 topic
- Mutational Signatures9▲ 54×1 topic
- Regulation8▲ 7.0×9 topics
- Metastasis8▲ 10×11 topics
- Genetic Mutations7▲ 7.4×16 topics
- Apoptosis7▲ 9.8×14 topics
- Cell Death7▲ 13×6 topics
- Clinical Practice Guidelines7▲ 5.3×9 topics
- Molecular Characterization6▲ 16×5 topics
- Radiotherapy6▲ 6.5×10 topics
- Transcriptional Regulation6▲ 16×9 topics
- Immune Checkpoint Blockade6▲ 21×1 topic
- Immunity6▲ 5.9×9 topics
- Neoadjuvant Therapy6▲ 10×5 topics
- PD-1 and PD-L16▲ 21×1 topic
- Stem Cells6▲ 8.8×12 topics
- Survival Analysis5▲ 8.7×6 topics
- Cancer Immunotherapy5▲ 15×3 topics
- Genomic Profiling5▲ 22×2 topics
- Lymphoma5▲ 14×4 topics
- Angiogenesis5▲ 6.7×11 topics
- Innate Immunity5▲ 6.9×9 topics
- Breast Cancer5▲ 8.5×9 topics
- Cancer Progression5▲ 12×7 topics
- Cell Proliferation5▲ 25×4 topics
Which research topics does Molecular Oncology (United States) publish most on?
By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Cancer, Hypoxia, and Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 9 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 6 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 4 Cancer, Hypoxia, and Metabolism Cancer Research 4 works
- 5 Epigenetics and DNA Methylation Molecular Biology 3 works
- 6 Cancer Cells and Metastasis Oncology 3 works
- 7 Genetic factors in colorectal cancer Pathology and Forensic Medicine 3 works
- 8 Glioma Diagnosis and Treatment Genetics 3 works
- 9 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 3 works
- 10 CAR-T cell therapy research Oncology 3 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Molecular Oncology (United States)'s research output changed?
Output in 2022-2025 was 16% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Molecular Oncology (United States) as a percentage of every work published that year, 0.00090% in 2024.
Fractional works of Molecular Oncology (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 35.1% in 1999.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Scientific Consulting Group
- Robotic Research (United States)
- GenVec
- CVPath Institute
- Identity
- Integrated BioTherapeutics (United States)
- Altimmune (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Molecular Oncology (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.
